Context Capital Management’s Gossamer Bio GOSS Stock Holding History

Context Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.76M	Buy	+28,946,459	New	+$8.08M	0.09%	128

Other funds holding GOSS

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Context Capital Management's GOSS Position: Q2 2026 in Review

Context Capital Management opened a new position in Gossamer Bio (GOSS) in Q2 2026: 28,946,459 shares worth $4.76M. The stake represents 0.09% of the portfolio and ranks #128 among its holdings.

27 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Context Capital Management held 28,946,459 shares of Gossamer Bio worth $4.76M as of Q2 2026.
Gossamer Bio was a new Context Capital Management position in Q2 2026.
Gossamer Bio made up 0.09% of Context Capital Management's portfolio in Q2 2026, its #128 holding.
27 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.